Status:
COMPLETED
Use of Muscle Relaxants in Parotidectomy Operation With Neuromonitoring
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Intubation; Difficult or Failed
Muscle Relaxation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Neuromuscular blockers provide muscle relaxation by blocking the electrical conduction to motor nerves and facilitate endotracheal tube placement while relaxing the whole body for surgical comfort dur...
Detailed Description
A general anesthesia technique is required, which will not only facilitate tracheal intubation during anesthesia but also minimize complications that may develop during and after surgery and/or anesth...
Eligibility Criteria
Inclusion
- ASA 1-2
- Age between 18-65y
- Mallampati 1-2
- Patients who will undergo elective paratidectomy
Exclusion
- History of head and neck surgery
- Body mass index less than 19 or greater than 30
- Muscle relaxant allergy
- Lidocaine allergy
- IDS score \>5
- Patients whose hunger is not suitable
- Uncontrolled hypertension, bronchial asthma, tracheal pathology
- undergoing emergency surgery
- Cases that cannot give informed consent
Key Trial Info
Start Date :
June 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05432570
Start Date
June 30 2022
End Date
December 30 2022
Last Update
March 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem Vakif University
Istanbul, Turkey (Türkiye)